tiprankstipranks
Argent Biopharma (AU:RGT)
ASX:RGT
Australian Market
RGT
Argent Biopharma
RESEARCH TOOLSreports

Argent Biopharma (RGT) Income Statement

6 Followers

Argent Biopharma Income Statement

Last quarter (Q4 2024), Argent Biopharma's total revenue was AU$115.14K. In Q4, Argent Biopharma's net income was AU$-3.71M. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 583.45KAU$ 891.08KAU$ 3.39MAU$ 4.73M
Gross Profit
AU$ 446.32KAU$ 203.70KAU$ 1.45MAU$ 1.81M
Operating Expenses
AU$ 15.89MAU$ 18.47MAU$ 17.05MAU$ 16.07M
Depreciation and Amortization
AU$ 789.14KAU$ 1.29MAU$ 751.94KAU$ 247.69K
EBITDA
AU$ -17.00MAU$ -15.77MAU$ -20.04MAU$ -16.70M
Operating Income
AU$ -15.44MAU$ -18.26MAU$ -15.60MAU$ -14.26M
Other Income/Expenses
AU$ -2.40MAU$ 713.39KAU$ -5.53MAU$ -2.88M
Pretax Income
AU$ -17.84MAU$ -17.55MAU$ -21.13MAU$ -17.14M
Net Income
AU$ -17.84MAU$ -17.53MAU$ -20.82MAU$ -16.77M
Per Share Metrics
Basic EPS
AU$ 0.00AU$ -0.47AU$ -7.10AU$ -6.50
Diluted EPS
AU$ 0.00AU$ -0.47AU$ -7.10AU$ -6.50
Weighted Average Shares Outstanding
 0.00 37.01M 2.94M 2.57M
Weighted Average Shares Outstanding (Diluted)
 0.00 37.01M 2.94M 2.57M
Currency in AUD

Argent Biopharma Earnings and Revenue History